| Recruiting | 2 | 450 | RoW | Denosumab 60 MG/ML, Prolia, Xgeva, Zoledronic Acid 5Mg/Bag 100Ml Inj, Zometa, Reclast, Aclasta, Sodium Chloride 0.9% or 5% Dextrose Intravenous, Saline, Placebo, Sodium Chloride 0.9% Injection | Australian and New Zealand Intensive Care Research Centre, Department of Health | Critical Illness, Osteoporosis | 02/27 | 02/27 | | |